Phenobarbitone in Rh Hemolytic Disease of the Newborn: A Randomized Double-Blinded Placebo-Controlled Trial

To evaluate the efficacy of prophylactic oral phenobarbitone (PB) in neonates with Rh hemolytic disease of the newborn. In this double-blind randomized trial conducted in a tertiary care unit, we randomly allocated neonates with Rh hemolytic disease of the newborn born at or after 32 weeks' ges...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of tropical pediatrics (1980) 2013-10, Vol.59 (5), p.380-386
Hauptverfasser: VENKATNARAYAN, Kannan, MARI JEEVA SANKAR, AGARWAL, Ramesh, PAUL, Vinod K, DEORARI, Ashok K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!